Security key
30050B101
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)
CUSIP: 30050B101
Q4 2025 13F Holders as of 31 Dec 2025
- Type / Class
- Equity / Class A Common Stock, par value $0.01 per share
- Shares outstanding
- 112,318,617
- Total 13F shares
- 120,528,795
- Share change
- -15,097,978
- Total reported value
- $482,118,679
- Put/Call ratio
- 220%
- Price per share
- $4.00
- Number of holders
- 211
- Value change
- -$146,972,693
- Number of buys
- 113
- Number of sells
- 121
Report period
Q4 2025
Institutions
211
Top holders
10
EVH full security history
Newer quarter: Q1 2026
Previous quarter: Q3 2025
Evolent Health, Inc. SEC filings
Evolent Health, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 30050B101
Recent filing periods:
Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| CADIAN CAPITAL MANAGEMENT, LP |
13D/G
13F
|
Company |
9.3%
|
10,794,606
|
$106,218,923 | $0 | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
13D/G
|
Company |
8.1%
from 13D/G
|
7,978,692
|
$67,499,747 | — | 30 Sep 2025 | |
| VANGUARD GROUP INC |
13F
13D/G
|
Company · The Vanguard Group |
8%
from 13D/G
|
10,966,830
|
$92,779,382 | — | 30 Sep 2025 | |
| Boehler Adam |
13D/G
|
Rubicon OP GP II LP |
5.2%
|
5,816,123
|
$49,204,401 | $0 | 13 Nov 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
13F
|
Company |
3.1%
|
3,577,197
|
$35,199,618 | $0 | 31 Dec 2024 | |
| FMR LLC |
13F
13D/G
|
Company |
0.7%
from 13D/G
|
8,749,996
|
$74,024,968 | — | 30 Sep 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13D/G
|
— |
0.4%
|
442,802
|
$5,016,947 | -$113,228,542 | 30 Jun 2025 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
13D/G
|
Company |
0%
from 13D/G
|
6,292,511
|
$53,245,678 | — | 30 Sep 2025 | |
| John Paul Johnson |
3/4/5
|
Chief Financial Officer |
0.28%
|
309,245
|
$2,576,010 | — | 01 Jul 2025 | |
| Peter J. Grua |
3/4/5
|
Director |
0.07%
|
82,647
|
$766,137 | — | 05 Jun 2025 | |
| Cheryl Scott |
3/4/5
|
Director |
0.07%
|
73,476
|
$681,122 | — | 05 Jun 2025 | |
| Richard M. Jelinek |
3/4/5
|
Director |
0.06%
|
66,437
|
$615,870 | — | 05 Jun 2025 | |
| Kim Keck |
3/4/5
|
Director |
0.05%
|
61,501
|
$570,114 | — | 05 Jun 2025 | |
| Brendan B. Springstubb |
3/4/5
|
Director |
0.05%
|
58,821
|
$224,690 | +$38,199 | 18 Nov 2025 | |
| Craig A. Barbarosh |
3/4/5
|
Director |
0.05%
|
53,935
|
$499,977 | — | 05 Jun 2025 | |
| Russell Monroe Glass |
3/4/5
|
Director |
0.04%
|
42,297
|
$392,092 | — | 05 Jun 2025 | |
| Toyin Ajayi |
3/4/5
|
Director |
0.03%
|
34,074
|
$315,865 | — | 05 Jun 2025 | |
| Shawn M. Guertin |
3/4/5
|
Director |
0.02%
|
21,979
|
$203,745 | — | 05 Jun 2025 | |
| BlackRock, Inc. |
13F
|
Company |
8.3%
|
9,314,161
|
$78,797,798 | — | 30 Sep 2025 | |
| Rubicon Founders LLC |
13F
|
Company |
5.2%
|
5,816,123
|
$49,204,401 | — | 30 Sep 2025 | |
| Engaged Capital LLC |
13F
|
Company |
5%
|
5,663,912
|
$47,916,696 | — | 30 Sep 2025 | |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
3.6%
|
4,035,475
|
$34,140,119 | — | 30 Sep 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.6%
|
4,001,077
|
$33,849,111 | — | 30 Sep 2025 | |
| UBS Group AG |
13F
|
Company |
3%
|
3,402,408
|
$28,784,371 | — | 30 Sep 2025 | |
| STATE STREET CORP |
13F
|
Company |
2.6%
|
2,974,573
|
$25,164,888 | — | 30 Sep 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
2.6%
|
2,950,000
|
$24,957,000 | — | 30 Sep 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.5%
|
2,757,037
|
$23,327,376 | — | 30 Sep 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
2.4%
|
2,737,796
|
$23,161,754 | — | 30 Sep 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
2.2%
|
2,509,051
|
$21,228,626 | — | 30 Sep 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
2.1%
|
2,395,284
|
$20,264,103 | — | 30 Sep 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2%
|
2,296,812
|
$19,431,030 | — | 30 Sep 2025 | |
| SILVERCREST ASSET MANAGEMENT GROUP LLC |
13F
|
Company |
1.6%
|
1,799,081
|
$15,220,225 | — | 30 Sep 2025 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
1.6%
|
1,773,818
|
$15,006,500 | — | 30 Sep 2025 | |
| 8 KNOTS MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
1,768,113
|
$14,958,236 | — | 30 Sep 2025 | |
| Sea Cliff Partners Management, LP |
13F
|
Company |
1.3%
|
1,466,867
|
$12,409,695 | — | 30 Sep 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
1.3%
|
1,442,168
|
$12,200,742 | — | 30 Sep 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.2%
|
1,397,270
|
$11,820,903 | — | 30 Sep 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1.2%
|
1,304,466
|
$11,035,782 | — | 30 Sep 2025 | |
| Glenmede Investment Management, LP |
13F
|
Company |
1.1%
|
1,238,477
|
$10,477,514 | — | 30 Sep 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1%
|
1,134,201
|
$9,595,341 | — | 30 Sep 2025 | |
| Rock Point Advisors, LLC |
13F
|
Company |
0.87%
|
978,449
|
$8,277,679 | — | 30 Sep 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.86%
|
961,797
|
$8,136,803 | — | 30 Sep 2025 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.82%
|
922,696
|
$7,806,008 | — | 30 Sep 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.78%
|
881,339
|
$7,456,128 | — | 30 Sep 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.77%
|
863,653
|
$7,306,504 | — | 30 Sep 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.76%
|
851,138
|
$7,200,627 | — | 30 Sep 2025 | |
| PEREGRINE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.67%
|
753,053
|
$6,370,828 | — | 30 Sep 2025 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
0.66%
|
744,891
|
$6,301,778 | — | 30 Sep 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.61%
|
689,262
|
$5,831,157 | — | 30 Sep 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.58%
|
654,747
|
$5,539,160 | — | 30 Sep 2025 |
Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q4 2025
As of 31 Dec 2025,
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by
211 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
120,528,795 shares.
The largest 10 holders included
CADIAN CAPITAL MANAGEMENT, LP, BlackRock, Inc., MORGAN STANLEY, VANGUARD GROUP INC, UBS Group AG, Rubicon Founders LLC, Engaged Capital LLC, D. E. Shaw & Co., Inc., JANE STREET GROUP, LLC, and JPMORGAN CHASE & CO.
This page lists
211
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
237
Q4 2025 holders
211
Holder diff
-26
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 Value $ | Q4 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.